SPONSOR

Yonsei University

Q: How many clinical trials has Yonsei University sponsored?

ClinicalMetric currently tracks 32 clinical trials sponsored by Yonsei University, of which 32 are actively recruiting participants. These trials cover conditions including Patent Foramen Ovale, Cryptogenic Stroke, Transient Ischemic Attack Due to Embolism. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

Q: What therapeutic areas does Yonsei University research focus on?

Yonsei University clinical trials span Patent Foramen Ovale, Cryptogenic Stroke, Transient Ischemic Attack Due to Embolism, Atrial Fibrillation, Acute Ischemic Stroke, and additional conditions. The research pipeline includes Phase 3, Phase 4, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

Q: How do I participate in a Yonsei University clinical trial?

To participate in a Yonsei University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Yonsei University trials with current recruitment status updated daily.

Total Trials

Recruiting

Phases

Phase 3, Phase 4, Phase 2, Phase 1, Phase 2

Conditions studied: Patent Foramen Ovale Cryptogenic Stroke Transient Ischemic Attack Due to Embolism Atrial Fibrillation Acute Ischemic Stroke Patients With Defibrillator Stroke ( 3 Months After Onset)Cognitive Dysfunction ( MMSE < 24 )Unilateral Neglect Syndrome Knee Osteoarthritis

Yonsei University is a clinical research sponsor with 32 registered studies on ClinicalTrials.gov, of which 32 are actively recruiting participants. Research covers conditions including Patent Foramen Ovale, Cryptogenic Stroke, Transient Ischemic Attack Due to Embolism, Atrial Fibrillation.

The trial portfolio spans Phase 3, Phase 4, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Yonsei University

How many clinical trials has Yonsei University sponsored?

ClinicalMetric currently tracks 32 clinical trials sponsored by Yonsei University, of which 32 are actively recruiting participants. These trials cover conditions including Patent Foramen Ovale, Cryptogenic Stroke, Transient Ischemic Attack Due to Embolism. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Yonsei University research focus on?

Yonsei University clinical trials span Patent Foramen Ovale, Cryptogenic Stroke, Transient Ischemic Attack Due to Embolism, Atrial Fibrillation, Acute Ischemic Stroke, and additional conditions. The research pipeline includes Phase 3, Phase 4, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Yonsei University clinical trial?

To participate in a Yonsei University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Yonsei University trials with current recruitment status updated daily.

Yonsei University

Frequently Asked Questions — Yonsei University

Clinical Trials by Yonsei University

Long-term Outcomes After Percutaneous Patent Foramen Ovale Closure (Severance PFO Registry)

Outcome in Patients Treated With Endovascular Thrombectomy - optIMAL Blood Pressure Control 2 (OPTIMAL-BP 2)

Economic and Clinical Benefit of Remote Monitoring Among Defibrillator Patients by Indication Subgroups (BENEFIT-RM)

The Effects of Virtual Reality-based Training for the Treatment of Neglect Syndrome in Stroke: a Randomized Controlled Trial

Comparison of Functional Recovery After Total Knee Arthroplasty Between Low Phase Angle and High Phase Angle Group

Comparison of Operator Radiation Exposure During Percutaneous Coronary Intervention Between Left Distal and Right Conventional Radial Access

Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR Study

Validation of the Prognostic Impact of a Retinal Photograph-based Cardiovascular Disease Risk Stratification System in de Novo HFrEF

Nutriomics and Artificial Intelligence Nutrition Obesity Cohort

Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma

Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA

A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients

Effectiveness and Safety of the Electrically Powered Orthopedic Exercise Device on Gait Ability in Patients With Hip Joint Diseases

Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia Patients After Stroke: A Randomized, Placebo-controlled, Double-blinded, Single Center Study

Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial

Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques

Comparison of Patient Understanding and Anxiety According to the Delivery Method of Educational Videos

Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation

Gangwon PCI Prospective Registry

SVF Cellular Composition, Secretome, and Responses in Knee Osteoarthritis

Fluctuational Imaging for the Diagnosis of Hepatic Hemangioma: A Multicenter, Prospective Study

A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury

Combination Therapy of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon for Complex Femoropopliteal Artery Disease

LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea

Effects of Nutritional Support on Postoperative Delirium

Pemetrexed, Cisplatin With Soft Tissue Sarcoma

Exercise Program in Patients With Nontuberculous Mycobacterial Pulmonary Disease

Registry Study on Rare Cancers in Korea

Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention

Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC)

Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >70 Years: the SCOPE-70 RCT Study